OBJECTIVE. FDG PET/CT affects the management of patients with breast cancer in multiple
settings, including initial staging, treatment response assessment, and evaluation of …

Currently, the clinical role of positron emission tomography (PET) and PET/computed
tomography (CT) in patients with breast cancer is to provide additional information in select …

Breast cancer is the most frequent cancer diagnosed in women worldwide. Accurate
baseline staging is necessary to plan optimal breast cancer management. Early detection …

Purpose We retrospectively reviewed FDG-PET/CT images in patients with breast cancer to
determine whether PET/CT improved the level of diagnostic confidence as compared with …

Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …

OBJECTIVE. Our aim was to evaluate the impact of FDG PET on defining the extent of
disease and on the treatment of patients with advanced breast cancer. MATERIALS AND …

BACKGROUND. Early diagnosis of recurrent breast cancer is crucial to selection of the most
appropriate therapy. The current study evaluated the role of FDG‐PET/CT in the assessment …

The aim of the present study was to investigate if 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography/computed tomography (PET/CT) outperforms conventional …

Purpose This retrospective study aimed (1) to compare the diagnostic accuracy of whole-
body FDG PET/CT for initial breast cancer staging with the accuracy of a conventional …